FMP
Laboratory Corporation of America Holdings
LH
NYSE
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.
245.73 USD
-3.03 (-1.23%)
Historical Prices
From:
To:
About
ceo
Mr. Adam H. Schechter
sector
Healthcare
industry
Medical - Equipment & Services
website
https://www.labcorp.comexchange
NYSE
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services compris...
CIK
0000920148
ISIN
US5049221055
CUSIP
504922105
Address
358 South Main Street
Phone
336 229 1127
Country
US
Employee
60,900
IPO Date
Mar 29, 1990
Financial Statement
Earnings
LH Financial Summary
CIK
0000920148
Exchange
NYSE
Industry
Medical - Equipment ...
Sector
Healthcare
CUSIP
504922105
ISIN
US5049221055
Country
US
Price
245.73
Beta
0.81
Volume Avg.
773.87k
Market Cap
20.56B
Shares
-
52-Week
191.97-258.59
DCF
394.61
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
28.31
P/B
-
Website
https://www.labcorp.com
Upgrades and Downgrades
Rating Distribution
TheFly
6 days ago
May 6, 2025
Neutral
Neutral
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest LH News
Alex Lavoie
3 days ago
DLH Holdings Corp. (NASDAQ:DLHC) Shows Strong Confidence and...
DLH Holdings Corp. (NASDAQ:DLHC) is a company that provides healthcare and logistics services to government agencies. It specializes in scientific research, development, and advanced technology services. DLHC's competitors include companies like Leidos and Booz Allen Hamilton, which also offer similar services to government clients. On May 8, 2025, Mink Brook Asset Management LLC, a significant shareholder of DLHC, purchased 140 shares of the company's common stock at $3.98 per share. This tra...
Davit Kirakosyan
Apr 21, 2025
Loop Capital Upgrades Norwegian Cruise Line on Valuation and...
Loop Capital upgraded Norwegian Cruise Line (NYSE:NCLH) to Buy from Hold, holding its price target steady at $25. The firm points to a compelling entry point after a roughly 40% drop in the stock year-to-date, noting the shares now trade at an attractive discount based on discounted cash flow valuations. Analysts are broadly optimistic about the cruise sector, viewing it as well-positioned to gain market share even in a downturn. Norwegian’s pricing—typically around 30% lower than comparable lan...
Davit Kirakosyan
Mar 31, 2025
Truist Upgrades Celsius to Buy, Shares Soar 6%
Celsius Holdings (NASDAQ:CELH) shares surged more than 6% intra-day today after Truist Securities upgraded the company to Buy, lifting its 12-month price target from $35 to $45, as the firm shifts focus toward the company’s long-term growth potential following its Alani Nu acquisition. Analysts noted that while Celsius has faced short-term challenges, including legacy business issues in 2024 and a slower start to Q1 2025, investor sentiment is now pivoting toward the strategic benefits of its la...
Rayan Ahmad
Feb 28, 2025
Alignment Healthcare, Inc. (NASDAQ:ALHC) Financial Performan...
Alignment Healthcare, Inc. (NASDAQ:ALHC) is a healthcare company that focuses on providing healthcare services to seniors. It operates primarily through its Medicare Advantage plans, aiming to offer personalized healthcare solutions. In the competitive landscape, ALHC faces peers like Privia Health Group, Inc. (PRVA), Agiliti, Inc. (AGTI), LifeStance Health Group, Inc. (LFST), agilon health, inc. (AGL), and Aveanna Healthcare Holdings Inc. (AVAH). ALHC's financial performance, particularly its ...
Davit Kirakosyan
Feb 27, 2025
Norwegian Cruise Line Delivers Strong Q4 Earnings, But 2025 ...
Norwegian Cruise Line (NYSE:NCLH) posted stronger-than-expected fourth-quarter earnings, as higher onboard spending fueled a jump in net yield. The cruise operator reported adjusted earnings per share of $0.26, more than double the $0.11 analysts had forecast. Revenue for the quarter reached $2.1 billion, aligning with expectations. The company’s net yield—a key measure of profitability—jumped 9% year-over-year, beating prior guidance by 210 basis points, thanks to robust guest spending on board...
Parth Sanghvi
Feb 21, 2025
Celsius Holdings (NASDAQ:CELH) Soars on Alani Nu Acquisition...
Key Highlights: Celsius Holdings’ stock surged 30% premarket after announcing a $1.8 billion acquisition of energy drink rival Alani Nu and posting better-than-expected Q4 earnings. The acquisition boosts Celsius's position in the high-growth functional beverage market, particularly among younger consumers. Despite missing revenue estimates slightly, Celsius posted strong EPS, reflecting operational efficiency. Celsius’s $1.8 Billion Alani Nu Acquisition: Strategic Expansion Celsius Hol...
Tony Dante
Feb 6, 2025
Labcorp's Promising Market Outlook and Financial Performance
Laboratory Corporation of America Holdings (NYSE: LH), commonly known as Labcorp, is a key player in the life sciences industry. The company provides a broad spectrum of diagnostic and drug development services. Labcorp's strategic collaborations, such as with the Tigerlily Foundation, aim to enhance clinical trial diversity, which may contribute to its favorable market outlook. Over the past year, analysts have shown increased confidence in Labcorp's stock, with the consensus price target risi...
Andrew Wynn
Jan 23, 2025
Goldman Sachs Sets Price Target for Norwegian Cruise Line Ho...
On January 23, 2025, Lizzie Dove from Goldman Sachs set a price target of $34 for Norwegian Cruise Line Holdings (NYSE:NCLH). At the time, the stock was trading at $26.42, suggesting a potential upside of about 28.69%. Norwegian Cruise Line Holdings operates 32 ships across three brands and competes with Carnival Corp. and Royal Caribbean. Norwegian Cruise Line Holdings is experiencing positive growth due to strong demand in the cruise industry. The company benefits from a surging global demand...
